Predictive utility of stress tests in the detection of asymptomatic coronary artery disease in atherosclerotic stroke patients.


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 20 02 2023
revised: 26 07 2023
accepted: 01 08 2023
medline: 4 9 2023
pubmed: 12 8 2023
entrez: 11 8 2023
Statut: ppublish

Résumé

Whether and how atherosclerotic ischemic stroke patients should be investigated for asymptomatic coronary artery disease (CAD) is controversial. Our aim was to carry out a prospective observational study to determine the frequency and predictors of functionally significant coronary stenosis in these patients as well as the predictors of major adverse cardiovascular events (MACE) during post-stroke follow-up. From January 2014 to June 2018, patients with atherosclerotic ischemic stroke were referred from the stroke unit to our cardiovascular department 3+/- 1 months after the acute event where they benefited from evaluation of cardiovascular risk factors, vascular and myocardial disease. Main outcome was defined as the prevalence of myocardial ischemia defined by perfusion stress echography 3 months after stroke. Secondary outcome (MACE) was defined as the incidence of stroke, transient ischemic attack (TIA), acute coronary syndrome, cardiovascular (CV) death or coronary or peripheral revascularization during a 3 year follow-up. Three hundred and twenty five patients (92% of strokes and 8% TIA) were included and median follow-up was 1075 days. At 3 months post-stroke, myocardial ischemia was found in 17 patients (5.2%). During the 3 year follow-up, 11 MACE occurred (3.4%, all in the non-ischemic group) of which 6 were recurrent strokes. In multivariate analysis, myocardial ischemia was significantly associated with the number of atheromatous vascular beds (OR 4.3; 95% CI, 1.7 to 10.6) and ECG signs of necrosis (OR 6.5; 95% CI, 1.9 to 21.9). MACE were also associated with ECG signs of necrosis (OR 3.5; 95% CI, 1.3 to 9.1), and unrelated to myocardial ischemia. Myocardial ischemia and CV events were infrequent and both strongly associated with ECG signs of necrosis, suggesting a low yield of stress tests and the potential for a more straightforward algorithm in the choice of patients eligible to coronary angiogram or other coronary imaging in post-stroke setting.

Identifiants

pubmed: 37567133
pii: S1052-3057(23)00313-0
doi: 10.1016/j.jstrokecerebrovasdis.2023.107290
pii:
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107290

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jean-Sébastien Liegey (JS)

CHU de Bordeaux, Service de Maladies Coronaires et Vasculaires, F-33600 Pessac, France. Electronic address: jean-sebastien.liegey@chu-bordeaux.fr.

Sami Fawaz (S)

CHU de Bordeaux, Service de Maladies Coronaires et Vasculaires, F-33600 Pessac, France. Electronic address: sami.fawaz@chu-bordeaux.fr.

Claire Ducos (C)

CHU de Bordeaux, Service de Maladies Coronaires et Vasculaires, F-33600 Pessac, France. Electronic address: claire.ducos@chu-bordeaux.fr.

Yann Pucheu (Y)

CHU de Bordeaux, Service de Maladies Coronaires et Vasculaires, F-33600 Pessac, France. Electronic address: yann.pucheu@chu-bordeaux.fr.

Romain Boulestreau (R)

CHU de Bordeaux, Service de Maladies Coronaires et Vasculaires, F-33600 Pessac, France. Electronic address: romain.boulestreau@chu-bordeaux.fr.

Igor Sibon (I)

CHU de Bordeaux, Service de Neurologie, Hopital Pellegrin, Rue de la Pelouse de Douet, Bordeaux, 33076, France. Electronic address: igor.sibon@chu-bordeaux.fr.

Thierry Couffinhal (T)

CHU de Bordeaux, Service de Maladies Coronaires et Vasculaires, F-33600 Pessac, France; Univ. Bordeaux, INSERM, Biologie des maladies cardiovasculaires, U1034, F-33600 Pessac, France. Electronic address: thierry.couffinhal@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH